Overview

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of EC-T and ET regimen as adjuvant treatment of breast cancer patients with positive lymph nodes
Phase:
Phase 3
Details
Lead Sponsor:
Chinese Academy of Medical Sciences
Treatments:
Albumin-Bound Paclitaxel
Epirubicin
Paclitaxel